|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
July
26, 2012, Taipei
A-Spine
received regulatory approval from
Dept of Health, Taiwan
to market Viscoseal, a hyaluronan preparation from TRB
CHEMEDICA, Germany.
Viscoseal is
currently the first and the only hyaluronan product with
approved indications for relief of pain and promotion of
joint recovery following arthroscopy or joint lavage.
Clinical studies confirm Viscoseal promotes pain relief,
reduces swelling and improves function in patients
recovering from arthroscopy.
A-Spine signed an
Agreement with TRB CHEMEDICA, Switzerland in 2008 for
the exclusive distribution of Viscoseal in Taiwan.
Viscoseal, the first non-spine product for A-Spine, will
be commercially launched in this September.
January
2, 2012, Taipei
A-Spine Asia (ASA)
entered into an agreement with Chindex Medical Limited
(CML) of Beijing, China for the distribution of ASA’s
SmartLoc®
Advanced Spinal Fixation System and Vigor PEEK Interbody
Fusion Cages in China.
The Distribution
Agreement was jointly signed on Dec. 29, 2011 at
FosunPharma headquarters in Shanghai by Mr. Ding Xiaojun,
CEO of CML and Mr. David Chang, President of ASA.
About
Chindex Medical Ltd.
(CML)
CML, a joint venture
company of Chindex International Inc. and Shanghai Fosun
Pharmaceutical (Group) Co., Ltd., is a leading supplier
of medical equipments with more than 1,500 employees
worldwide and headquartered in USA and China. For
further information about CML and FosunPharma, you may
visit the websites at
www.chindexmedical.com and/or
www.fosunpharma.com.
About
A-Spine Asia Co., Ltd.
(ASA)
ASA, a private-owned
medical device company based in NeiHu Technology Park,
Taipei, is a leading manufacturer of spinal implants and
instruments. Smartloc®, a top-loading screw / rod spinal
fixation system developed by ASA received FDA 510(k)
clearance in 2011. Vigor® PEEK Interbody Fusion Cages,
cervical and lumabr are made from PEEK-OPTIMA® of
Invibio USA. These two products have already been
approved by China SFDA and will be officially launched
in China by CML during second quarter of 2012. For
further information about ASA, please visit
www.aspine.com.tw or by email to
service@aspine.com.tw.
|
|
|
|
October
24, 2011,
Taipei
A-Spine Asia Receives FDA 510(K) Clearance for SmartLoc®
Spinal
Fixation System
A-Spine Asia announced
today that it has received 510(K) clearance from the
U.S. Food and Drug Administration to market the SmartLoc®
Spinal Fixation System.
It is the first
product from A-Spine Asia receiving 510(K) clearance.
SmartLoc®
is a top-loading pedicle screw spinal fixation system
intended to provide immobilization and stabilization of
thoracic, lumbar, and sacral spinal segments as an
adjunct to fusion.
Since its official
launch in 2006 till now, more than 20,000 procedures
have been performed with this system in Taiwan. For
further information about SmartLoc®
and other products from A-Spine Asia please visit
www.aspine.com.tw
or directly contact A-Spine Asia by email to
service@aspine.com.tw.
October 9, 2009,
Taipei
Clinical report for Latero PEEK--Fusion
Rate of A Novel LumbarInterbody Fixation Device:
Intravertebral Plate and Cage Sytem
August
24, 2009,
Taipei
A-Spine
Asia receives DOH approval to market the Segmental
Spinal Correction System (SSCS), a dynamic stabilization
system from Ulrich Medical, Germany (www.ulrichmedical.com).
This
unique dynamic system will be officially launched in
January 2010. . A-Spine Asia is the exclusive
distributor in Taiwan for the spinal implants from
Ulrich Medical.
July
8, 2009,
Taipei
A-Spine
Asia receives DOH approval to market geneX Putty, a
newly developed bone graft with 510(k) clearance from
Biocomposites, UK (www.biocomposites.com).
A-Spine Asia is the exclusive distributor in Taiwan for
the synthetic bone graft products from Biocomposites.
|
|
|
|
Medical
Congress and Exhibition Calendar 2008
Visit us at any of these upcoming Spine Meetings and
Conventions
continue to read ...
|
|
|
|
October 11, 2007
A-Spine Asia wins Taipei
Biotechnology Award Again
A-Spine
Asia wins 2007 Taipei-Bio Bronze Medal Award in the
category of “Commercialization” with a cash prize of
NT$400,000.- (equivalent to US$12,300).
continue to read ...
|
|
|
|
Medical Congress and Exhibition Calendar 2007
Visit us at any of these upcoming Spine
Meetings and Conventions
continue to read ...
|
|
|
|
December
1, 2006,
Taipei
A-Spine Asia received marketing approval
from Dept. of Health (DOH) in Taiwan for the imported
products Add & AddPlus from
Ulrich Medical, Germany.
As the exclusive distributor for Ulrich Medical, A-Spine
Asia is planning to officially launch Add/AddPlus
in Taiwan in January 2007. VBR, another product from
Ulrich will be launched soon after receiving
DOH’s approval.
|
|
|
|
February 1, 2006,
Taipei
A-Spine Asia entered into an exclusive distribution
agreement with Biocomposites
UK for bone graft products in Taiwan.
Based on this agreement,
Biocomposites’ products
Stimulan, GeneX,
Allogran-N and
Allogran-R will be launched
in Taiwan in second half of 2006.
|
|
|
|
February 26,
2004,
Taipei
A-Spine Asia
obtained ISO9001/13485 and “CE” Marking approvals for
Spinal Fixation, Metal Disc Spacer, Polymer Disc Spacer,
and Instruments for Spinal Surgery.
|
|
|
| |
December 15, 2003,
Taipei
A-Spine Asia
obtained cGMP (Currently Good Manufacturing Practice)
and various product registration approvals from
Department of Health in Taiwan.
|
|
|
|
|
|
